Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
Georgette D Kanmogne1, Sangya Singh1, Upal Roy1, Xinming Liu1, JoEllyn McMillan1, Santhi Gorantla1, Shantanu Balkundi1, Nathan Smith1, Yazen Alnouti2, Nagsen Gautam2, You Zhou3, Larisa Poluektova1, Alexander Kabanov2, Tatiana Bronich2, Howard E Gendelman11Departments of Pharmacology and Experimental...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a99a17a8bab45da873bc130440f710f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2a99a17a8bab45da873bc130440f710f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2a99a17a8bab45da873bc130440f710f2021-12-02T05:55:47ZMononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells1176-91141178-2013https://doaj.org/article/2a99a17a8bab45da873bc130440f710f2012-05-01T00:00:00Zhttp://www.dovepress.com/mononuclear-phagocyte-intercellular-crosstalk-facilitates-transmission-a9851https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Georgette D Kanmogne1, Sangya Singh1, Upal Roy1, Xinming Liu1, JoEllyn McMillan1, Santhi Gorantla1, Shantanu Balkundi1, Nathan Smith1, Yazen Alnouti2, Nagsen Gautam2, You Zhou3, Larisa Poluektova1, Alexander Kabanov2, Tatiana Bronich2, Howard E Gendelman11Departments of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, 2Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE; 3Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, USAAbstract: Despite the successes of antiretroviral therapy (ART), HIV-associated neurocognitive disorders remain prevalent in infected people. This is due, in part, to incomplete ART penetration across the blood–brain barrier (BBB) and lymph nodes and to the establishment of viral sanctuaries within the central nervous system. In efforts to improve ART delivery, our laboratories developed a macrophage-carriage system for nanoformulated crystalline ART (nanoART) (atazanavir, ritonavir, indinavir, and efavirenz). We demonstrate that nanoART transfer from mononuclear phagocytes (MP) to human brain microvascular endothelial cells (HBMEC) can be realized through cell-to-cell contacts, which can facilitate drug passage across the BBB. Coculturing of donor MP containing nanoART with recipient HBMEC facilitates intercellular particle transfer. NanoART uptake was observed in up to 52% of HBMEC with limited cytotoxicity. Folate coating of nanoART increased MP to HBMEC particle transfer by up to 77%. To translate the cell assays into relevant animal models of disease, ritonavir and atazanavir nanoformulations were injected into HIV-1-infected NOD/scid-γcnull mice reconstituted with human peripheral blood lymphocytes. Atazanavir and ritonavir levels in brains of mice treated with folate-coated nanoART were three- to four-fold higher than in mice treated with noncoated particles. This was associated with decreased viral load in the spleen and brain, and diminished brain CD11b-associated glial activation. We postulate that monocyte-macrophage transfer of nanoART to brain endothelial cells could facilitate drug entry into the brain.Keywords: nanoART, folate, monocyte-endothelial cell interactions, blood–brain barrier, antiretroviral therapy, nanomedicineKanmogne GDSingh SRoy ULiu XMcMillan JGorantla SBalkundi SSmith NAlnouti YGautam NZhou YPoluektova LKabanov ABronich TGendelman HEDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 2373-2388 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Kanmogne GD Singh S Roy U Liu X McMillan J Gorantla S Balkundi S Smith N Alnouti Y Gautam N Zhou Y Poluektova L Kabanov A Bronich T Gendelman HE Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells |
description |
Georgette D Kanmogne1, Sangya Singh1, Upal Roy1, Xinming Liu1, JoEllyn McMillan1, Santhi Gorantla1, Shantanu Balkundi1, Nathan Smith1, Yazen Alnouti2, Nagsen Gautam2, You Zhou3, Larisa Poluektova1, Alexander Kabanov2, Tatiana Bronich2, Howard E Gendelman11Departments of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, 2Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE; 3Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, USAAbstract: Despite the successes of antiretroviral therapy (ART), HIV-associated neurocognitive disorders remain prevalent in infected people. This is due, in part, to incomplete ART penetration across the blood–brain barrier (BBB) and lymph nodes and to the establishment of viral sanctuaries within the central nervous system. In efforts to improve ART delivery, our laboratories developed a macrophage-carriage system for nanoformulated crystalline ART (nanoART) (atazanavir, ritonavir, indinavir, and efavirenz). We demonstrate that nanoART transfer from mononuclear phagocytes (MP) to human brain microvascular endothelial cells (HBMEC) can be realized through cell-to-cell contacts, which can facilitate drug passage across the BBB. Coculturing of donor MP containing nanoART with recipient HBMEC facilitates intercellular particle transfer. NanoART uptake was observed in up to 52% of HBMEC with limited cytotoxicity. Folate coating of nanoART increased MP to HBMEC particle transfer by up to 77%. To translate the cell assays into relevant animal models of disease, ritonavir and atazanavir nanoformulations were injected into HIV-1-infected NOD/scid-γcnull mice reconstituted with human peripheral blood lymphocytes. Atazanavir and ritonavir levels in brains of mice treated with folate-coated nanoART were three- to four-fold higher than in mice treated with noncoated particles. This was associated with decreased viral load in the spleen and brain, and diminished brain CD11b-associated glial activation. We postulate that monocyte-macrophage transfer of nanoART to brain endothelial cells could facilitate drug entry into the brain.Keywords: nanoART, folate, monocyte-endothelial cell interactions, blood–brain barrier, antiretroviral therapy, nanomedicine |
format |
article |
author |
Kanmogne GD Singh S Roy U Liu X McMillan J Gorantla S Balkundi S Smith N Alnouti Y Gautam N Zhou Y Poluektova L Kabanov A Bronich T Gendelman HE |
author_facet |
Kanmogne GD Singh S Roy U Liu X McMillan J Gorantla S Balkundi S Smith N Alnouti Y Gautam N Zhou Y Poluektova L Kabanov A Bronich T Gendelman HE |
author_sort |
Kanmogne GD |
title |
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells |
title_short |
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells |
title_full |
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells |
title_fullStr |
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells |
title_full_unstemmed |
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells |
title_sort |
mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells |
publisher |
Dove Medical Press |
publishDate |
2012 |
url |
https://doaj.org/article/2a99a17a8bab45da873bc130440f710f |
work_keys_str_mv |
AT kanmognegd mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT singhs mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT royu mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT liux mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT mcmillanj mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT gorantlas mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT balkundis mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT smithn mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT alnoutiy mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT gautamn mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT zhouy mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT poluektoval mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT kabanova mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT bronicht mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells AT gendelmanhe mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells |
_version_ |
1718400161675214848 |